Altered expression of cell cycle genes distinguishes aggressive neuroblastoma

Oncogene

Volumn 24, Issue 9, 2005, Pages 1533-1541

  Krasnoselsky, Alexei L ^a   Whiteford, Craig C ^a   Wei, Jun S ^a   Bilke, Sven ^a   Westermann, Frank ^b   Chen, Qing Rong ^a   Khan, Javed ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

Cdna microarray; Gene expression; Gene ontology; MYCN; Neuroblastoma; Principal component analysis

Indexed keywords

COMPLEMENTARY DNA;

ARTICLE; CANCER STAGING; CELL CYCLE; CENTROMERE; CHROMOSOME SEGREGATION; CONTROLLED STUDY; DNA MICROARRAY; GENE AMPLIFICATION; GENE EXPRESSION; GENE EXPRESSION PROFILING; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; NEUROBLASTOMA; PHENOTYPE; PRINCIPAL COMPONENT ANALYSIS; PRIORITY JOURNAL; UPREGULATION; GENE EXPRESSION REGULATION; GENETICS; HUMAN CHROMOSOME; ONCOGENE MYC; PATHOLOGY;

CELL CYCLE; CHROMOSOME SEGREGATION; CHROMOSOMES, HUMAN; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, MYC; HUMANS; NEOPLASM STAGING; NEUROBLASTOMA; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PHENOTYPE;

EID: 14944371239     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1208341     Document Type: Article

References (32)

1. Alaminos M, Mora J, Cheung NK, Smith A, Qin J, Chen L and Gerald WL. (2003). Cancer Res., 63, 4538-4546.
2. Alter O, Brown PO and Botstein D. (2000). Proc. Natl. Acad. Sci. USA, 97, 10101-10106.
3. Ashburner M, Ball CA, Blake JA, Botstein D, Butler H. Cherry JM, Davis AP, Dolinski K, Dwight SS, Eppig JT, Harris MA, Hill DP, Issel-Tarver L, Kasarskis A, Lewis S. Matese JC, Richardson JE, Ringwald M, Rubin GM and Sherlock G. (2000). Nat. Genet., 25, 25-29.
4. Berwanger B, Hartmann O, Bergmann E, Bernard S, Nielsen D, Krause M, Kartal A, Flynn D, Wiedemeyer R, Schwab M, Schafer H, Christiansen H and Eilers M. (2002). Cancer Cell, 2, 377-386.
5. Boon K, Caron HN, van Asperen R, Valentijn L, Hermus MC, van Sluis P, Roobeek I, Weis I, Voute PA, Schwab M and Versteeg R. (2001). EMBO J., 20, 1383-1393.
6. Brodeur GM. (2003). Nat. Rev. Cancer, 3, 203-216.
7. Chen Y, Kamat V, Dougherty ER, Bittner ML, Meltzer PS and Trent JM. (2002). Bioinformatics, 18, 1207-1215.
8. Cohn SL, Rademaker AW, Salwen HR, Franklin WA, Gonzales-Crussi F, Rosen ST and Bauer KD. (1990). Am. J. Pathol., 136, 1043-1052.
9. Dominici C, Negroni A, Romeo A, McDowell H, Padula A, Pucci S, Cappelli C, Castello MA and Raschella G. (1992). Anticancer Res., 12, 59-63.
10. Ewart-Toland A, Briassouli P, de Koning JP, Mao JH, Yuan J. Chan F, MacCarthy-Morrogh L, Ponder BA, Nagase H, Burn J, Ball S, Almeida M, Linardopoulos S and Balmain A. (2003). Nat. Genet., 34, 403-412.
11. Fernandez PC, Frank SR, Wang L, Schroeder M, Liu S, Greene J, Cocito A and Amati B. (2003). Genes Dev., 17, 1115-1129.
12. Hegde P, Qi R, Abernathy K, Gay C, Dharap S, Gaspard R, Hughes JE, Snesrud E, Lee N and Quackenbush J. (2000). Biotechniques, 29, 548-550, 552-554, 556 passim.
13. Islam A, Kageyama H, Takada N, Kawamoto T, Takayasu H, Isogai E, Ohira M, Hashizume K, Kobayashi H, Kaneko Y and Nakagawara A. (2000). Oncogene, 19, 617-623.
14. Khan J, Wei JS, Ringner M, Saal LH, Ladanyi M, Westermann F, Berthold F, Schwab M, Antonescu CR, Peterson C and Meltzer PS. (2001). Nat. Med., 7, 673-679.
15. Li F, Ambrosini G, Chu EY, Plescia J, Tognin S, Marchisio PC and Altieri DC. (1998). Nature, 396, 580-584.
16. McArdle L, McDermott M, Purcell R, Grehan D, O'Meara A, Breatnach F, Catchpoole D, Culhane AC, Jeffery I, Gallagher WM and Stallings RL. (2004). Carcinogenesis, 9, 1599-1609.
17. Mora J, Gerald WL and Cheung NK. (2003). Cancer Lett., 197, 119-124.
18. Negroni A, Scarpa S, Romeo A, Ferrari S, Modesti A and Raschella G. (1991). Cell Growth Differ., 2, 511-518.
19. Ruggero D and Pandolfi PP. (2003). Nat. Rev. Cancer. 3, 179-192.
20. Schmidt ML, Salwen HR, Manohar CF, Ikegaki N and Cohn SL. (1994). Cell Growth Differ., 5, 171-178.
21. Schwab M, Westermann F, Hero B and Berthold F. (2003). Lancet Oncol., 4, 472-480.
22. Schweigerer L, Breit S, Wenzel A, Tsunamoto K, Ludwig R and Schwab M. (1990). Cancer Res., 50, 4411-4416.
23. Sugihara E, Kanai M, Matsui A, Onodera M, Schwab M and Miwa M. (2004). Oncogene, 23, 1005-1009.
24. Takita J, Ishii M, Tsutsumi S, Tanaka Y, Kato K, Toyoda Y, Kanada R, Yamamoto K, Hayashi Y and Aburatani H. (2004). Genes Chromosomes Cancer, 40, 120-132.
25. Tonini GP and Romani M. (2003). Cancer Lett., 197, 69-73.
26. van Noesel MM and Versteeg R. (2004). Gene, 325, 1-15.
27. Wang E, Miller LD, Ohnmacht GA, Liu ET and Marincola FM. (2000). Nat. Biotechnol., 18, 457-459.
28. Wei JS, Greer BT, Westermann F, Steinberg SM, Son CG, Chen QR, Whiteford CC, Bilke S, Krasnoselsky AL, Cenacchi N, Catchpoole D, Berthold F, Schwab M and Khan J. (2004). Cancer Res., 64, 6883-6891.
29. Wei JS and Khan J. (2002). DNA Microarrays: A Molecular Cloning Manual Bowtell D and SJ (eds). Cold Spring Harbor Laboratory Press: Cold Spring Harbor. New York, pp. 110-119.
30. Westermann F and Schwab M. (2002). Cancer Lett., 184, 127-147.
31. Zar JH. (1999). Biostatistical Analysis. Prentice-Hall: Upper Saddle River, NJ.
32. Zhou H, Kuang J, Zhong L, Kuo WL, Gray JW, Sahin A, Brinkley BR and Sen S. (1998). Nat. Genet., 20, 189-193.